Friday, June 23, 2023

We Will Elaborate On This Theme, When Back From The Mountains… Grin.


For now, suffice it to say that we've long labeled these three as the serialization of a triumvirate of self important greed -- over faithful life sciences corporate stewardship.

I'll have more on my return, but recall the Forbes headline of eight years ago, now -- as did FiercePharma last February:

. . .In 2015, Saunders became the subject of a Forbes cover story titled “Wall Street’s Drug Dealer: Five Years, Three Companies, $100 billion in M&A -- and Zero Inventions. The 44-year-old Future of Medicine. . . .”


Pulling into a very familiar stone driveway, and smiling into the cool night air of the Rockies, now. . . .

नमस्ते

No comments: